These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10823574)

  • 1. Ts65Dn mouse, a Down syndrome model, exhibits elevated myo-inositol in selected brain regions and peripheral tissues.
    Shetty HU; Siarey RJ; Galdzicki Z; Stoll J; Rapoport SI
    Neurochem Res; 2000 Apr; 25(4):431-5. PubMed ID: 10823574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain accumulation of myo-inositol in the trisomy 16 mouse, an animal model of Down's syndrome.
    Shetty HU; Holloway HW; Acevedo LD; Galdzicki Z
    Biochem J; 1996 Jan; 313 ( Pt 1)(Pt 1):31-3. PubMed ID: 8546700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyol profiles in Down syndrome. myo-Inositol, specifically, is elevated in the cerebrospinal fluid.
    Shetty HU; Schapiro MB; Holloway HW; Rapoport SI
    J Clin Invest; 1995 Feb; 95(2):542-6. PubMed ID: 7860736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain myo-inositol level is elevated in Ts65Dn mouse and reduced after lithium treatment.
    Huang W; Galdzicki Z; van Gelderen P; Balbo A; Chikhale EG; Schapiro MB; Rapoport SI
    Neuroreport; 2000 Feb; 11(3):445-8. PubMed ID: 10718292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal expression of the G-protein-activated inwardly rectifying potassium channel 2 (GIRK2) in hippocampus, frontal cortex, and substantia nigra of Ts65Dn mouse: a model of Down syndrome.
    Harashima C; Jacobowitz DM; Witta J; Borke RC; Best TK; Siarey RJ; Galdzicki Z
    J Comp Neurol; 2006 Feb; 494(5):815-33. PubMed ID: 16374808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of stable isotope tracer combined with mass spectrometric detection for studying myo-inositol uptake by cultured neurons from fetal mouse: effect of trisomy 16.
    Acevedo LD; Holloway HW; Rapoport SI; Shetty HU
    J Mass Spectrom; 1997 Apr; 32(4):395-400. PubMed ID: 9130398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations of central noradrenergic transmission in Ts65Dn mouse, a model for Down syndrome.
    Dierssen M; Vallina IF; Baamonde C; García-Calatayud S; Lumbreras MA; Flórez J
    Brain Res; 1997 Feb; 749(2):238-44. PubMed ID: 9138724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal microRNA expression in Ts65Dn hippocampus and whole blood: contributions to Down syndrome phenotypes.
    Keck-Wherley J; Grover D; Bhattacharyya S; Xu X; Holman D; Lombardini ED; Verma R; Biswas R; Galdzicki Z
    Dev Neurosci; 2011; 33(5):451-67. PubMed ID: 22042248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic analysis of six- and twelve-month hippocampus and cerebellum in a murine Down syndrome model.
    Vacano GN; Gibson DS; Turjoman AA; Gawryluk JW; Geiger JD; Duncan M; Patterson D
    Neurobiol Aging; 2018 Mar; 63():96-109. PubMed ID: 29245059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ts65Dn, a mouse model of Down syndrome, exhibits increased GABAB-induced potassium current.
    Best TK; Siarey RJ; Galdzicki Z
    J Neurophysiol; 2007 Jan; 97(1):892-900. PubMed ID: 17093127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasoactive intestinal peptide in the brain of a mouse model for Down syndrome.
    Hill JM; Ades AM; McCune SK; Sahir N; Moody EM; Abebe DT; Crnic LS; Brenneman DE
    Exp Neurol; 2003 Sep; 183(1):56-65. PubMed ID: 12957488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo 1H MRS study in microlitre voxels in the hippocampus of a mouse model of Down syndrome at 11.7 T.
    Santin MD; Valabrègue R; Rivals I; Pénager R; Paquin R; Dauphinot L; Albac C; Delatour B; Potier MC
    NMR Biomed; 2014 Oct; 27(10):1143-50. PubMed ID: 25088227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of Myo-Inositol Transporter SMIT1 Normalizes Cholinergic and Glutamatergic Function in an Immortalized Cell Line Established from the Cerebral Cortex of a Trisomy 16 Fetal Mouse, an Animal Model of Human Trisomy 21 (Down Syndrome).
    Cárdenas AM; Fernández-Olivares P; Díaz-Franulic I; González-Jamett AM; Shimahara T; Segura-Aguilar J; Caviedes R; Caviedes P
    Neurotox Res; 2017 Nov; 32(4):614-623. PubMed ID: 28695546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of correlations among proteins in brains of the Ts65Dn mouse model of down syndrome.
    Ahmed MM; Sturgeon X; Ellison M; Davisson MT; Gardiner KJ
    J Proteome Res; 2012 Feb; 11(2):1251-63. PubMed ID: 22214338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of voltage-activated calcium channels in cultured hippocampal neurons from mouse trisomy 16, a model for Down syndrome.
    Galdzicki Z; Coan EJ; Rapoport SI; Stoll J
    Brain Res Mol Brain Res; 1998 May; 56(1-2):200-6. PubMed ID: 9602127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Widespread cerebellar transcriptome changes in Ts65Dn Down syndrome mouse model after lifelong running.
    Walus M; Kida E; Rabe A; Albertini G; Golabek AA
    Behav Brain Res; 2016 Jan; 296():35-46. PubMed ID: 26304719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that increased Kcnj6 gene dose is necessary for deficits in behavior and dentate gyrus synaptic plasticity in the Ts65Dn mouse model of Down syndrome.
    Kleschevnikov AM; Yu J; Kim J; Lysenko LV; Zeng Z; Yu YE; Mobley WC
    Neurobiol Dis; 2017 Jul; 103():1-10. PubMed ID: 28342823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trisomy for the Down syndrome 'critical region' is necessary but not sufficient for brain phenotypes of trisomic mice.
    Olson LE; Roper RJ; Sengstaken CL; Peterson EA; Aquino V; Galdzicki Z; Siarey R; Pletnikov M; Moran TH; Reeves RH
    Hum Mol Genet; 2007 Apr; 16(7):774-82. PubMed ID: 17339268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of p53 in Down Syndrome and in the Ts65Dn Mouse Brain is Associated with a Pro-Apoptotic Phenotype.
    Tramutola A; Pupo G; Di Domenico F; Barone E; Arena A; Lanzillotta C; Brokeaart D; Blarzino C; Head E; Butterfield DA; Perluigi M
    J Alzheimers Dis; 2016; 52(1):359-371. PubMed ID: 26967221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and genetic localization of Down syndrome cerebellar phenotypes using the Ts65Dn mouse.
    Baxter LL; Moran TH; Richtsmeier JT; Troncoso J; Reeves RH
    Hum Mol Genet; 2000 Jan; 9(2):195-202. PubMed ID: 10607830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.